Biosev S.A. Announced earnings results for the third quarter ended December 31, 2018. For the third quarter, the company announced sales was BRL 1,559.926 million compared to BRL 1,535.433 million a year ago. Operating loss was BRL 90.745 million compared to operating Income of BRL 104.205 million a year ago. Net loss was BRL 230.441 million compared to BRL 278.626 million a year ago. Basic loss per share was BRL 0.48508 compared to BRL 1.29736 a year ago. For the nine months, sales was BRL 4,959.069 million compared to BRL 5,147.716 million a year ago. Operating loss was BRL 95.962 million compared to BRL 146.399 million a year ago. Net loss was BRL 892.201 million compared to BRL 823.162 million a year ago. Basic loss per share was BRL 2.68943 compared to BRL 3.84362 a year ago.